Abstract 1959: Sensitive detection of circulating tumor DNA by whole genome sequencing: Validation of MRDetect using serial blood samples from stage III colorectal cancer patients
Amanda Frydendahl(Aarhus University), Claus L. Andersen(Aarhus University), Lene Hjerrild Iversen(Aarhus University Hospital), Anders Husted Andersen(Regionshospitalet Herning), Noah Friedman(University of California, San Diego), Kandasamy Ravi(ID Genomics (United States)), Iman Tavassoly(ID Genomics (United States)), Danielle Afterman(IBM Research - Haifa), Sunil Deochand(ID Genomics (United States)), Uffe S. Løve(Regionshospitalet Viborg), Tomer Lauterman(IBM Research - Haifa), Nidhi Ramaraj, Dillon Maloney(ID Genomics (United States)), Kåre Andersson Gotschalck(Regional Hospital Randers), Ronel Veksler(IBM Research - Haifa), Thomas Reinert(Aarhus University Hospital), Asaf Zviran(Q Therapeutics (United States)), Imane Bourzgui, Boris Oklander(IBM Research - Haifa), Ole Thorlacius‐Ussing(Aalborg University), Jonathan Rosenfeld, Zohar Donenhirsh(IBM Research - Haifa), Jesper Nors(Aarhus University), Per Vadgaard Andersen(Odense University Hospital)
Cited by 1
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Direct detection of early-stage cancers using circulating tumor DNA
|Science Translational Medicine|2017|1.1k
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer
|JAMA Oncology|2019|992
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654